492 related articles for article (PubMed ID: 19149599)
21. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.
Busso N; Karababa M; Nobile M; Rolaz A; Van Gool F; Galli M; Leo O; So A; De Smedt T
PLoS One; 2008 May; 3(5):e2267. PubMed ID: 18493620
[TBL] [Abstract][Full Text] [Related]
22. Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine.
Grolla AA; Travelli C; Genazzani AA; Sethi JK
Br J Pharmacol; 2016 Jul; 173(14):2182-94. PubMed ID: 27128025
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma.
Grolla AA; Torretta S; Gnemmi I; Amoruso A; Orsomando G; Gatti M; Caldarelli A; Lim D; Penengo L; Brunelleschi S; Genazzani AA; Travelli C
Pigment Cell Melanoma Res; 2015 Nov; 28(6):718-29. PubMed ID: 26358657
[TBL] [Abstract][Full Text] [Related]
24. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
[TBL] [Abstract][Full Text] [Related]
25. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
Burgos ES
Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
[TBL] [Abstract][Full Text] [Related]
26. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity.
Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M
J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196
[TBL] [Abstract][Full Text] [Related]
27. Nampt/PBEF/Visfatin: a new player in beta cell physiology and in metabolic diseases?
Tanaka T; Nabeshima Y
Cell Metab; 2007 Nov; 6(5):341-3. PubMed ID: 17983577
[TBL] [Abstract][Full Text] [Related]
28. Nampt/PBEF/visfatin and cancer.
Bi TQ; Che XM
Cancer Biol Ther; 2010 Jul; 10(2):119-25. PubMed ID: 20647743
[TBL] [Abstract][Full Text] [Related]
29. Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD(+) protects the heart against pressure overload.
Yano M; Akazawa H; Oka T; Yabumoto C; Kudo-Sakamoto Y; Kamo T; Shimizu Y; Yagi H; Naito AT; Lee JK; Suzuki J; Sakata Y; Komuro I
Sci Rep; 2015 Nov; 5():15857. PubMed ID: 26522369
[TBL] [Abstract][Full Text] [Related]
30. The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.
Chen X; Zhao S; Song Y; Shi Y; Leak RK; Cao G
Curr Top Med Chem; 2015; 15(21):2211-21. PubMed ID: 26059356
[TBL] [Abstract][Full Text] [Related]
31. The role of visfatin/ NAMPT in the regulation of feeding in goldfish (Carassius auratus).
Butler MJ; Volkoff H
Peptides; 2023 Feb; 160():170919. PubMed ID: 36503895
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.
Liu LY; Wang F; Zhang XY; Huang P; Lu YB; Wei EQ; Zhang WP
PLoS One; 2012; 7(10):e44933. PubMed ID: 23071504
[TBL] [Abstract][Full Text] [Related]
33. NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair.
Wang P; Li WL; Liu JM; Miao CY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):474-81. PubMed ID: 26485210
[TBL] [Abstract][Full Text] [Related]
34. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker.
Semerena E; Nencioni A; Masternak K
Front Immunol; 2023; 14():1268756. PubMed ID: 37915565
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD+ synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry.
Hara N; Osago H; Hiyoshi M; Kobayashi-Miura M; Tsuchiya M
PLoS One; 2019; 14(3):e0214000. PubMed ID: 30875389
[TBL] [Abstract][Full Text] [Related]
37. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review.
Gasparrini M; Giovannuzzi S; Nocentini A; Raffaelli N; Supuran CT
Expert Opin Ther Pat; 2024 Jul; 34(7):565-582. PubMed ID: 38861278
[TBL] [Abstract][Full Text] [Related]
39. [Importance of NAMPT-mediated NAD-biosynthesis and NAD-dependent deacetylase SIRT1 in the crosstalk between circadian rhythm and metabolism].
Yoshino J
Nihon Rinsho; 2013 Dec; 71(12):2187-93. PubMed ID: 24437277
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
